Loading clinical trials...
Loading clinical trials...
Evaluation of CT Perfusion Parameters as a Potential Biomarker for Treatment Response in Pancreatic Cancer
Conditions
Interventions
Computed Tomography Perfusion Imaging
Locations
1
United States
Fred Hutch/University of Washington Cancer Consortium
Seattle, Washington, United States
Start Date
June 22, 2017
Primary Completion Date
June 1, 2022
Completion Date
June 1, 2022
Last Updated
July 6, 2022
NCT04657068
NCT06445062
NCT04900818
NCT07432633
NCT04851119
NCT06005493
Lead Sponsor
University of Washington
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions